We are live on
!
Find out more
WPP
Whalerock Point Partners Portfolio holdings
AUM
$518M
1-Year Est. Return
25.26%
This Fund
S&P 500
This Quarter
Est. Return
-1.96%
1 Year Est. Return
+25.26%
3 Year Est. Return
+92.14%
5 Year Est. Return
+122.34%
10 Year Est. Return
–
AUM
$242M
AUM Growth
-$3.49M
(-1.4%)
Cap. Flow
+$3.27M
Cap. Flow
% of AUM
1.35%
Top 10 Holdings %
Top 10 Hldgs %
50.74%
Holding
156
New
8
Increased
81
Reduced
23
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$702K |
| 2 |
WisdomTree Europe Hedged Equity Fund
HEDJ
|
+$503K |
| 3 |
Gilead Sciences
GILD
|
+$456K |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$453K |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$363K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTC Therapeutics
PTCT
|
+$1.17M |
| 2 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$763K |
| 3 |
VRTV
VERITIV CORPORATION
VRTV
|
+$641K |
| 4 |
Check Point Software Technologies
CHKP
|
+$615K |
| 5 |
Micron Technology
MU
|
+$603K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 39.05% |
| 2 | Healthcare | 13.61% |
| 3 | Industrials | 9.85% |
| 4 | Energy | 7.23% |
| 5 | Technology | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
Micron Technology
MU
$959B
| – | – |
-22,250
| Closed | -$603K |
|
|
152
PTC Therapeutics
PTCT
$6.52B
| – | – |
-19,225
| Closed | -$1.17M |
|
153
ProShares UltraShort S&P500
SDS
$390M
| – | – |
-277
| Closed | -$590K |
|
|
VRTV
154
DELISTED
VERITIV CORPORATION
VRTV
| – | – |
-14,541
| Closed | -$641K |
|
|
CHK
155
DELISTED
Chesapeake Energy Corporation
CHK
| – | – |
-96
| Closed | -$270K |
|
|
DTV
156
DELISTED
DIRECTV COM STK (DE)
DTV
| – | – |
-8,975
| Closed | -$763K |
|
Similar funds
WS
LHC
PTP
WP
OIS
CI
AAM
GSAM
Whalerock Point Partners's Q2 2015 Portfolio in Review
As of Q2 2015, Whalerock Point Partners held 156 positions worth $242M, down 1.4% from $245M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Whalerock Point Partners's Q2 2015 filing shows 8 new, 81 increased, 23 reduced and 8 closed positions. Its largest new stake was Vanguard Mid-Cap ETF: 9,808 shares worth $312K. The largest sale was PTC Therapeutics, an estimated $1.17M.
By sector, the portfolio is most concentrated in Financials at 39% of assets, down from 39% a quarter earlier, followed by Healthcare and Industrials.
- Whalerock Point Partners's largest Q2 2015 buy was Vanguard Mid-Cap ETF: 9,808 shares worth $312K.
- Whalerock Point Partners added most to JPMorgan Chase in Q2 2015, an estimated $702K increase.
- Whalerock Point Partners's biggest Q2 2015 reduction was Berkshire Hathaway Class A, cutting an estimated $215K.
- Whalerock Point Partners fully exited PTC Therapeutics in Q2 2015, selling an estimated $1.17M.
- Whalerock Point Partners's ten largest holdings make up 51% of its $242M portfolio in Q2 2015.
- Whalerock Point Partners opened 8 new positions and closed 8 in Q2 2015.
- Whalerock Point Partners's portfolio value fell 1.4% quarter-over-quarter to $242M.
Based on Whalerock Point Partners's 13F filing for Q2 2015, filed 28 Jul 2015.